NOTICE OF UPGRADE
Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022
SEARCH LISTED COMPANY
Any AUS or NZ company
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
06 October 2024
| Name: | TYRIAN DIAGNOSTICS LIMITED (TDX) (This company subsequently changed its name to ASSOCIATE GLOBAL PARTNERS LIMITED. You should refer to that name for Status.) | |||||||||
| Date of Listing: | 30 September 2004 | |||||||||
| Subsequent Names: |
| |||||||||
| Former Names: |
|
Stock Exchange Status: (updated daily)
This company subsequently changed its name to ASSOCIATE GLOBAL PARTNERS LIMITED. You should refer to that name for Stock Exchange Status.Legal Status: (updated monthly)
This company subsequently changed its name to ASSOCIATE GLOBAL PARTNERS LIMITED. You should refer to that name for Legal Status.Capital Gains Tax (CGT) Status: (updated at least quarterly)
This company subsequently changed its name and is now ASSOCIATE GLOBAL PARTNERS LIMITED. You should refer to that name for Capital Gains Tax Status.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| FROM | TO | |
| ASSOCIATE GLOBAL PARTNERS LIMITED | 18/11/2022 | |
| CONTANGO ASSET MANAGEMENT LIMITED | 08/09/2016 | 18/11/2022 |
| TYRIAN DIAGNOSTICS LIMITED | 19/11/2008 | 08/09/2016 |
| PROTEOME SYSTEMS LIMITED | 19/11/2008 |
Link Market Services Limited Sydney
Level 12, 680 George Street
Sydney NSW 2000
Tel : 61 1300 554 474
Fax : 02 9287 0303
RegistryWebsite RegistryEmail
Expand this box to read and print
name changed to Contango Asset Management Limited | 08/09/2016 |
we understand that on or about this date the company consolidated its shares 1 for 300 | 06/09/2016 |
The lodged replacement prospectus is for a public offering of 28,643,300 Shares (post Share Consolidation) at an Offer Price of $0.60 each to raise $17,185,980. | 31/08/2016 |
The company advises that it has lodged a replacement prospectus with ASIC dated 31 August 2016 which replaces the original prospectus lodged on 18 August 2016. | 31/08/2016 |
The company releases the results of its meeting. | 25/08/2016 |
The company releases the chairman's address to shareholders at extraordinary general meeting. | 25/08/2016 |
The company announces that it has today lodged its prospectus dated 18 August 2016 with ASIC for a public offer of 28,643,000 Shares (post share consolidation) at an offer price of $0.60 (post share consolidation) each to raise $17,185,980 (Offer). This Prospectus is issued for the purpose of also re-complying with the admission requirements under Chapters 1 and 2 of the ASX Listing Rules following a change to the nature and scale of the Company's activities. | 18/08/2016 |
The company lodges its Preliminary final report for the year ending 30 June 2016. | 18/08/2016 |
Shareholders get 1 share for every 300 they presently hold. | 26/07/2016 |
Notice is given that an extraordinary meeting will be held at 9:00 AM (AEST) on Thursday, 25 August 2016, at the offices of K&L Gates, Level 31, 1 O'Connell Street, Sydney NSW 2000. | 26/07/2016 |
The company lodges its quarterly report. | 18/07/2016 |
The securities of Tyrian Diagnostics Limited will be suspended from quotation immediately, following receipt of an announcement regarding its proposed change of activities. The Company's securities will remain suspended until the Company has complied with Chapters 1 and 2 of the Listing Rules in accordance with Listing Rule 11.1.3. | 24/06/2016 |
the suspension of trading in the securities of Tyrian Diagnostics Limited (the "Company") will be lifted from the commencement of trading on Thursday, 18 November 2010, in accordance with listing rule 17.7, following an announcement by the Company in relation to a capital raising | 18/11/2010 |
the securities of Tyrian Diagnostics Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending an announcement with regard to a proposed capital raising | 17/11/2010 |
name changed from Proteome Systems Limited | 19/11/2008 |
name changed to Contango Asset Management Limited | 08/09/2016 |
we understand that on or about this date the company consolidated its shares 1 for 300 | 06/09/2016 |
The lodged replacement prospectus is for a public offering of 28,643,300 Shares (post Share Consolidation) at an Offer Price of $0.60 each to raise $17,185,980. | 31/08/2016 |
The company advises that it has lodged a replacement prospectus with ASIC dated 31 August 2016 which replaces the original prospectus lodged on 18 August 2016. | 31/08/2016 |
The company releases the results of its meeting. | 25/08/2016 |
The company releases the chairman's address to shareholders at extraordinary general meeting. | 25/08/2016 |
The company announces that it has today lodged its prospectus dated 18 August 2016 with ASIC for a public offer of 28,643,000 Shares (post share consolidation) at an offer price of $0.60 (post share consolidation) each to raise $17,185,980 (Offer). This Prospectus is issued for the purpose of also re-complying with the admission requirements under Chapters 1 and 2 of the ASX Listing Rules following a change to the nature and scale of the Company's activities. | 18/08/2016 |
The company lodges its Preliminary final report for the year ending 30 June 2016. | 18/08/2016 |
Shareholders get 1 share for every 300 they presently hold. | 26/07/2016 |
Notice is given that an extraordinary meeting will be held at 9:00 AM (AEST) on Thursday, 25 August 2016, at the offices of K&L Gates, Level 31, 1 O'Connell Street, Sydney NSW 2000. | 26/07/2016 |
The company lodges its quarterly report. | 18/07/2016 |
The securities of Tyrian Diagnostics Limited will be suspended from quotation immediately, following receipt of an announcement regarding its proposed change of activities. The Company's securities will remain suspended until the Company has complied with Chapters 1 and 2 of the Listing Rules in accordance with Listing Rule 11.1.3. | 24/06/2016 |
the suspension of trading in the securities of Tyrian Diagnostics Limited (the "Company") will be lifted from the commencement of trading on Thursday, 18 November 2010, in accordance with listing rule 17.7, following an announcement by the Company in relation to a capital raising | 18/11/2010 |
the securities of Tyrian Diagnostics Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending an announcement with regard to a proposed capital raising | 17/11/2010 |
name changed from Proteome Systems Limited | 19/11/2008 |
Your browser may reflect a date of printing in American format.
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Roger Amos | Chairman | 18/06/2007 |
| George Boubouras | Managing Director | 25/08/2016 |
| Andrew Blunden | CFO, Company Secretary | 24/02/2012 |
| Charlie Aitken | Non Exec Director | 25/08/2016 |
| Martin Switzer | Non Exec Director | 25/08/2016 |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Simon O'Loughlin | Non Exec Director | 23/02/2016 | 25/08/2016 |
| Merilyn Sleigh | Non Exec Director | 28/11/2008 | 25/08/2016 |
| Caroline Popper | Non Exec Director | 12/12/2007 | 23/02/2016 |
| Jenny Harry | CEO, Director | 09/03/2005 | 24/02/2012 |
| Lisa Jones | General Counsel | 01/08/2004 | 24/02/2012 |
| Michael Vamos | CFO | 02/02/2010 | 24/11/2011 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2024 Investogain Pty Limited. All rights reserved.
